ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 303 filers reported holding ALKERMES PLC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,703,000 | +134.9% | 76,245 | +213.2% | 0.10% | +197.1% |
| Q2 2022 | $725,000 | +13.3% | 24,344 | +0.1% | 0.04% | -2.8% |
| Q1 2022 | $640,000 | -74.6% | 24,310 | -77.6% | 0.04% | -61.7% |
| Q4 2021 | $2,523,000 | +74.8% | 108,475 | +131.8% | 0.09% | +25.3% |
| Q3 2021 | $1,443,000 | +236.4% | 46,787 | +167.4% | 0.08% | +316.7% |
| Q2 2021 | $429,000 | -79.3% | 17,498 | -84.3% | 0.02% | -84.5% |
| Q1 2021 | $2,075,000 | +316.7% | 111,106 | +344.7% | 0.12% | +182.9% |
| Q4 2020 | $498,000 | +6.6% | 24,984 | -11.3% | 0.04% | -19.6% |
| Q3 2020 | $467,000 | +65.0% | 28,177 | +43.3% | 0.05% | +50.0% |
| Q1 2020 | $283,000 | -33.4% | 19,660 | -5.7% | 0.03% | -2.9% |
| Q4 2019 | $425,000 | -72.8% | 20,844 | -74.0% | 0.04% | -63.2% |
| Q3 2019 | $1,561,000 | -22.7% | 80,035 | -10.7% | 0.10% | -45.7% |
| Q2 2019 | $2,019,000 | +130.5% | 89,584 | +201.9% | 0.18% | -32.7% |
| Q4 2018 | $876,000 | – | 29,675 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 2,639,676 | $96,322,000 | 7.78% |
| Meditor Group Ltd | 892,400 | $32,564,000 | 6.11% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233,000 | $8,502,000 | 3.14% |
| Tamarack Advisers, LP | 140,000 | $5,109,000 | 2.03% |
| Asymmetry Capital Management, L.P. | 27,673 | $1,010,000 | 1.69% |
| First Light Asset Management, LLC | 211,164 | $7,705,000 | 1.00% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 304,992 | $11,129,000 | 0.85% |
| Nicollet Investment Management, Inc. | 28,020 | $1,022,000 | 0.67% |
| PRIMECAP MANAGEMENT CO/CA/ | 23,263,530 | $848,886,000 | 0.62% |
| Rhenman & Partners Asset Management AB | 120,399 | $4,393,000 | 0.51% |